ORIC PHARMACEUTICALS INC (ORIC) Institutional Ownership Changes & 13F Activity
ORIC PHARMACEUTICALS INC (ORIC). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include D. E. Shaw & Co., Inc., Price T Rowe Associates Inc, Goldman Sachs Group Inc, Alkeon Capital Management Llc, and Adage Capital Partners Gp, L.L.C..
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Manufacturers Life Insurance Company, The | Sell | -7,917 | -4.3% | 174,222 | $1.89M | Q2 2026 | Sep 09, 2026 |
| Citadel Advisors Llc | Buy | +172,558 | +7.1% | 2,595,299 | $28.11M | Q2 2026 | Sep 02, 2026 |
| Optimize Financial Inc | Sell | -112 | -0.3% | 32,216 | $348.90K | Q2 2026 | Aug 27, 2026 |
| California State Teachers Retirement System | Buy | +23,691 | +49.0% | 72,060 | $780.41K | Q2 2026 | Aug 24, 2026 |
| D. E. Shaw & Co., Inc. | Buy | +1,535,826 | +3459.8% | 1,580,216 | $17.11M | Q2 2026 | Aug 14, 2026 |
| Price T Rowe Associates Inc | Buy | +1,229,771 | +22.8% | 6,617,554 | $71.67M | Q2 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Buy | +976,084 | +66.1% | 2,451,796 | $26.55M | Q2 2026 | Aug 14, 2026 |
| Alkeon Capital Management Llc | Sell | -765,000 | -17.0% | 3,739,096 | $40.49M | Q2 2026 | Aug 14, 2026 |
| Adage Capital Partners Gp, L.L.C. | Buy | +707,588 | +205.5% | 1,051,903 | $11.39M | Q2 2026 | Aug 14, 2026 |
| Viking Global Investors | Sell | -697,771 | -12.0% | 5,126,762 | $55.52M | Q2 2026 | Aug 14, 2026 |
| Orbimed Advisors Llc | Sell | -678,929 | -25.2% | 2,015,000 | $21.82M | Q2 2026 | Aug 14, 2026 |
| Millennium Management Llc | Buy | +663,682 | +1951.3% | 697,694 | $7.56M | Q2 2026 | Aug 14, 2026 |
| Two Sigma Investments, Lp | Buy | +603,664 | — | 603,664 | $6.54M | Q2 2026 | Aug 14, 2026 |
| Integral Health Asset Management, Llc | Buy | +500,000 | +35.7% | 1,900,000 | $20.58M | Q2 2026 | Aug 14, 2026 |
| Balyasny Asset Management L.P. | Sell | -499,589 | -95.4% | 24,201 | $262.10K | Q2 2026 | Aug 14, 2026 |
| Squarepoint Ops Llc | Buy | +344,343 | — | 344,343 | $3.73M | Q2 2026 | Aug 14, 2026 |
| Superstring Capital Management Lp | Buy | +290,843 | +252.4% | 406,077 | $4.40M | Q2 2026 | Aug 14, 2026 |
| Royce & Associates Lp | Sell | -227,559 | -18.8% | 979,664 | $10.61M | Q2 2026 | Aug 14, 2026 |
| Sphera Funds Management Ltd. | Buy | +215,355 | +40.1% | 752,983 | $8.15M | Q2 2026 | Aug 14, 2026 |
| Defilade Capital Management, L.P. | Buy | +204,762 | +24.3% | 1,047,690 | $11.35M | Q2 2026 | Aug 14, 2026 |
| Trexquant Investment Lp | Buy | +197,847 | +825.3% | 221,819 | $2.40M | Q2 2026 | Aug 14, 2026 |
| Aqr Capital Management Llc | Buy | +188,664 | +110.9% | 358,751 | $3.89M | Q2 2026 | Aug 14, 2026 |
| Nextbio Capital Management Lp | Buy | +182,505 | +34.9% | 706,124 | $7.65M | Q2 2026 | Aug 14, 2026 |
| Xtx Topco Ltd | Buy | +174,536 | +403.2% | 217,827 | $2.36M | Q2 2026 | Aug 14, 2026 |
| Boxer Capital Management, Llc | Buy | +173,500 | +98.3% | 350,000 | $3.79M | Q2 2026 | Aug 14, 2026 |
| Hrt Financial Lp | Buy | +153,245 | — | 153,245 | $1.66M | Q2 2026 | Aug 14, 2026 |
| Susquehanna International Group, Llp | Buy | +116,211 | +504.1% | 139,266 | $1.51M | Q2 2026 | Aug 14, 2026 |
| Invesco Ltd. | Buy | +107,773 | — | 107,773 | $1.17M | Q2 2026 | Aug 14, 2026 |
| Atom Investors Lp | Sell | -96,725 | -42.6% | 130,079 | $1.41M | Q2 2026 | Aug 14, 2026 |
| Braidwell Lp | Buy | +86,500 | +7.7% | 1,214,540 | $13.15M | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about ORIC activity
Which institutional owners are buying ORIC?
Institutional owners buying ORIC include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in ORIC activity?
"Buy" means an investor increased their reported position in ORIC compared to the prior reporting period. This reflects growing exposure to ORIC PHARMACEUTICALS INC (ORIC) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in ORIC increasing?
Institutional interest in ORIC can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related ORIC Institutional Insights
- ORIC Overview
- ORIC 13F Institutional Holders
- ORIC Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- ORIC Insider Trading & SEC Form 4 Activity
- ORIC Articles
- Top Institutional Investor Stock Rankings